Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Unraveling the role of the adaptor protein Stimulator of Interferon Genes (STING) in kidney disease
EF 2023-24
Résumé
Kidney disease is a major health problem that affects over two million Canadians. Our kidneys filter waste products from our blood into our urine. If kidney disease gets very bad and a person’s kidneys stop working, then the only treatment options are to clean the waste products from the blood (called dialysis) or to transplant in a new kidney from a donor. The good news is that there have been recent advances in preventative treatments that can reduce the likelihood of someone getting kidney disease or kidney failure. However, these treatments aren’t perfect, and we still need to discover new treatment approaches to stop kidney disease. When kidney disease happens it often causes something to happen in the kidneys called ‘inflammation’. The term ‘inflammation’ describes our body’s immune response to infection or damage, attracting white blood cells to clear up the damage. When inflammation happens in response to infection this can be a good thing because it can help our bodies clear the infection. However, when inflammation happens and there is no infection, for example in kidney disease, then the inflammation can make things worse. Recently a small protein present in our cells has been discovered that controls inflammation. That protein is called STING, and it is thought that if we can block the actions of STING we might be able to stop kidney disease. In my project, I am using experimental models to work out in which cells in the kidneys STING may be harmful. Once we have figured this out, my findings could help develop a new treatment for kidney disease that works by targeting specific cells in the kidney. Such a targeted approach could avoid potential harmful effects (like unwanted infections) that can occur when the whole immune system is blocked.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506571
Name
Yeung Emily S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Unraveling the role of the adaptor protein Stimulator of Interferon Genes (STING) in kidney disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Kidney Injury; Chronic Kidney Disease; Immune Cells; Inflammation; Macrophages; Nephorology; Sting; Tubule Cells; Unilateral Ureteral Obstruction
Abstract
Kidney disease is a major health problem that affects over two million Canadians. Our kidneys filter waste products from our blood into our urine. If kidney disease gets very bad and a person’s kidneys stop working, then the only treatment options are to clean the waste products from the blood (called dialysis) or to transplant in a new kidney from a donor. The good news is that there have been recent advances in preventative treatments that can reduce the likelihood of someone getting kidney disease or kidney failure. However, these treatments aren’t perfect, and we still need to discover new treatment approaches to stop kidney disease. When kidney disease happens it often causes something to happen in the kidneys called ‘inflammation’. The term ‘inflammation’ describes our body’s immune response to infection or damage, attracting white blood cells to clear up the damage. When inflammation happens in response to infection this can be a good thing because it can help our bodies clear the infection. However, when inflammation happens and there is no infection, for example in kidney disease, then the inflammation can make things worse. Recently a small protein present in our cells has been discovered that controls inflammation. That protein is called STING, and it is thought that if we can block the actions of STING we might be able to stop kidney disease. In my project, I am using experimental models to work out in which cells in the kidneys STING may be harmful. Once we have figured this out, my findings could help develop a new treatment for kidney disease that works by targeting specific cells in the kidney. Such a targeted approach could avoid potential harmful effects (like unwanted infections) that can occur when the whole immune system is blocked.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yeung, Emily S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~